DS have proved efficacy against H274Y tami resistant swine flu - It was probably a given - but something that needed proving under the current circumstances(another obstacle cleared)
Antimicrob Agents Chemother. 2010 Jan 4. [Epub ahead of print]
CS-8958 ( laninamivir prodrug), a long-acting neuraminidase inhibitor, shows superior
anti-influenza virus activity after a single administration.
Kubo S, Tomozawa T, Kakuta M, Tokumitsu A, Yamashita M.
Biological Research Laboratories IV, Daiichi Sankyo Co. Ltd., 1-2-58, Hiromachi, Shinagawa, Tokyo 140-8710, Japan.
... CS-8958 administered just once 7 days before infection showed significant efficacy in vivo. {mice ?}
Then, the efficacy by a single administration of CS-8958 after viral infection was compared with
that by repeated administrations of oseltamivir phosphate or zanamivir in mice and ferrets
and CS-8958 showed superior or similar efficacy to the two licensed NA inhibitors.
CS-8958 also significantly reduced the virus titers of an oseltamivir-resistant H1N1 virus with a neuraminidase H274Y substitution in a mouse infection model.
__________________
- Forums
- ASX - By Stock
- BTA
- lani results out
lani results out
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online